鼓室内注射激素作为补充治疗或初始治疗突发性聋的疗效分析

陈敬彩, 杨军, 贾欢, 等. 鼓室内注射激素作为补充治疗或初始治疗突发性聋的疗效分析[J]. 临床耳鼻咽喉头颈外科杂志, 2015, 29(19): 1691-1694. doi: 10.13201/j.issn.1001-1781.2015.19.006
引用本文: 陈敬彩, 杨军, 贾欢, 等. 鼓室内注射激素作为补充治疗或初始治疗突发性聋的疗效分析[J]. 临床耳鼻咽喉头颈外科杂志, 2015, 29(19): 1691-1694. doi: 10.13201/j.issn.1001-1781.2015.19.006
CHEN Jingcai, YANG Jun, JIA Huan, et al. Efficacy of intratympanic steroid injection as supplementary or initial treatment for sudden sensorineural hearing loss[J]. J Clin Otorhinolaryngol Head Neck Surg, 2015, 29(19): 1691-1694. doi: 10.13201/j.issn.1001-1781.2015.19.006
Citation: CHEN Jingcai, YANG Jun, JIA Huan, et al. Efficacy of intratympanic steroid injection as supplementary or initial treatment for sudden sensorineural hearing loss[J]. J Clin Otorhinolaryngol Head Neck Surg, 2015, 29(19): 1691-1694. doi: 10.13201/j.issn.1001-1781.2015.19.006

鼓室内注射激素作为补充治疗或初始治疗突发性聋的疗效分析

详细信息
    通讯作者: 杨军,E-mail:otology-xinhua@hotmail.com
  • 中图分类号: R764.43

Efficacy of intratympanic steroid injection as supplementary or initial treatment for sudden sensorineural hearing loss

More Information
  • 目的: 观察鼓室内注射激素作为补充治疗或初始治疗突发性聋的疗效。方法: 68例被确诊为突发性聋的患者被随机分为A组45例(其中全身用激素33例,全身用激素后听力改善不佳再鼓室内注射激素作为补充治疗12例)、B组23例(鼓室内注射激素初始治疗),观察各组疗效。结果: A、B两组总有效率分别为55.6%和56.5%,2组比较差异无统计学意义(P>0.05)。A组中全身使用激素后听力改善不佳再鼓室内注射激素作为补充治疗的12例患者鼓室内注射激素前后PTA差异有统计学意义(P<0.05)。结论: 全身或鼓室内注射激素治疗突发性聋均有效,鼓室内注射激素补充治疗或初始治疗突发性聋与全身用激素疗效相同,推荐将鼓室内注射激素作为全身激素治疗后疗效欠佳的补充治疗,亦可作为初始治疗。
  • 加载中
  • [1]

    施俊,杨军,吴皓,等.鼓室内注射地塞米松治疗特发性突聋的临床研究[J].临床耳鼻咽喉科杂志,2006,20(16):749-751.

    [2]

    杨军,黄莉,施俊等.鼓室内注射地塞米松或甲泼尼龙治疗突发性耳聋的疗效观察[J].临床耳鼻咽喉头颈外科杂志,2010,24(13):594-597.

    [3]

    PARK M K, LEE C K, PARK K H, et al. Simultaneous versus subsequent intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss[J]. Otolaryngol Head Neck Surg, 2011, 145:1016-1021.

    [4]

    付发祥,宋蕾.鼓室注射地塞米松治疗伴糖尿病突发性耳聋的临床研究[J].中国耳鼻咽喉颅底外科杂志,2012,18(1):38-40.

    [5]

    赵晖,张天宇,傅窈窈,等.鼓室内注射地塞米松治疗极重度以上突发性聋的临床研究[J].中华耳鼻咽喉头颈外科杂志,2009,44(4):297-301.

    [6]

    DALIAN I, DE VITO A, FATTORI B, et al. Intratympanic methylprednisolone in refractory sudden hearing loss:a 27-patient case series with univariate and multivariate analysis[J]. Otol Neurotol, 2010,31:25-30.

    [7]

    STACHLER R J, CHANDRASEKHAR S S, ARC-HER S M, et al. Clinical practice guideline:sudden hearing loss[J]. Otolaryngol Head Neck Surgery, 2012,146(3 suppl):S1-S35.

    [8]

    中华耳鼻咽喉头颈外科杂志编辑委员会,中华医学会耳鼻咽喉头颈外科学分会.突发性聋的诊断和治疗指南(2005年,济南)[J].中华耳鼻咽喉头颈外科杂志,2006,41(8):569-569.

    [9]

    CHOU Y F, CHEN P R, KUO I J, et al. Comparison of intermittent intratympanic steroid injection and near-continual transtympanic steroid perfusion as salvage treatments for sudden sensorineural hearing loss[J]. Laryngoscope, 2013, 123:2264-2269.

    [10]

    VAN W F, STAECKER H, LEFEBVRE P P. Topical steroid therapy using the Silverstein Microwick in sudden sensorineural hearing loss after failure of conventional treatment[J]. Acta Otolaryngol, 2007,127:1012-1017.

    [11]

    VLASTARAKOS P V, PAPACHARALAMPOUS G, MARAGOUDAKI P, et al. Are intra-tympanically administered steroids effective in patients with sudden deafness?Implications for current clinical practice[J]. Eur Arch Otorhinolaryngol, 2012, 269:363-380.

    [12]

    RAUCH S D, HALPIN C F, ANTONELLI P J, et al. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss:a randomized trial[J]. JAMA, 2011, 30:2071-2079.

    [13]

    DISPENZA F, AMODIO E, DE STEFANO A, et al. Treatment of sudden sensorineural hearing loss with transtympanic injection of steroids as single therapy:a randomized clinical study[J]. Eur Arch Otorhinolaryngol, 2011, 268:1273-1278.

    [14]

    KANZAKI S, FUJIOKA M, YASUDA A, et al. Novel in vivo imaging analysis of an inner ear drug delivery system in mice:comparison of inner ear drug concentrations over time after transtympanic and systemic injections[J]. PLoS One, 2012,7:e48480.

    [15]

    刘阳云,张彩霞,曹杭,等.突发性耳聋挽救性治疗时机[J].临床耳鼻咽喉头颈外科杂志,2015,29(8):719-722.

  • 加载中
计量
  • 文章访问数:  68
  • PDF下载数:  46
  • 施引文献:  0
出版历程
收稿日期:  2015-05-29

目录